No definition recorded for this entity.
Wiki pages (5)
SciDEX wiki entries that cover this entity. Different pages may focus on the gene, protein, or disease aspects of the same canonical id.
- ALK Protein
ALK Protein ALK [@stynen2015] Protein Name Anaplastic Lymphoma Kinase Gene
Read more → - HNRNPD Gene
ALK["NPM-ALK"] -->|"interacts with"| HNRNPD["HNRNPD"] style HNRNPD fill
Read more → - TGF-β/BMP Signaling Pathway in Neurodegeneration
ALK - Activin receptor-Like Kinases): **Type I Receptors (ALKs):** - **ALK1/2
Read more → - Zellweger Syndrome
alk-1'-enyl-2-acyl-sn-glycero-3-phospholipids) are a subclass
Read more → - ACVR2B Gene
ALKs - activin receptor-like kinases). The activated type I receptor
Read more →
Graph neighborhood (3 nodes · 3 edges)
Click a neighbor to navigate · double-click opens in a new tab · open in full graph viewer
Related hypotheses
- Kinase Inhibitor-C1q Structural Convergence for Bifunctional Drug Design
starts from the claim that modulating C1QA/C1QB/C1QC, ALK, SYK within the disease context of neuroinflammation ... starts from the claim that modulating C1QA/C1QB/C1QC, ALK, SYK w…
- C1q Binding Analysis Across ALK Inhibitor Chemical Series Would Resolve Specificity
Mechanistic Overview C1q Binding Analysis Across ALK Inhibitor Chemical Series Would Resolve Specificity starts from ... reads: "## Mechanistic Overview C1q Binding Analysis Acros…
- Transferrin-Alectinib Conjugation Enhances Blood-Brain Barrier Transport via Transferrin Receptor-Mediated Endocytosis
transferrin-TfR1 binding affinity, and maintained alectinib ALK kinase inhibitory activity. In vitro studies using ... plasma ratios and improved efficacy against intracranial ALK…
- Direct C1q Binding Enables FcγR-Independent Complement Activation on Tumor Cells
complement-dependent cytotoxicity (CDC), providing an ALK-independent antitumor mechanism (identifier: 33850120). This links ... patient populations. 5. Alectinib's efficacy is AL…
- C1q-Alectinib Complexation Disrupts Tight Junction Integrity to Enable Paracellular Brain Penetration
penetration of tyrosine kinase inhibitors in treating ALK-positive brain metastases. The hypothesis predicts that ... demonstrates superior CNS penetration versus earlier-generati…